Background: Though matrix metalloproteinase 2 (MMP-2) involvement in tumor aggressiveness and invasion is well-known, its prognostic impacts still remain largely controversial. Furthermore, the correlations between MMP-2 and epithelial-mesenchymal transition (EMT) have not been directly established in nasopharyngeal carcinoma (NPC). Materials and methods: The purpose of this study was to investigate MMP-2 expression in NPC. Tissue microarrays from 144 patients with NPC and 45 non-cancerous pharynx tissues were analyzed for MMP-2 expression by immunohistochemistry. MMP-2 expression in relation to clinicopathological characteristics and EMT were assessed in NPC. Tumorinvasive potential affected by exogenous expression of MMP-2 in NPC cells was also detected in vitro. Results: Compared to normal nasopharyngeal epithelium, high expression of tumoral MMP-2 was detected in 47.9% of NPC samples. Significant association was found between MMP-2 expression and various aggressive features including T classification, M classification and tumor stage (P<0.05). Of note, high expression of MMP-2 was prominently observed at tumor invasive front, neoplastic spindle cells migrating into the stroma and vessel invasion. Importantly, high MMP-2 expression predicted worse survival in patients with stage III-IV (P=0.039). Overexpression of MMP-2 could decrease cell-cell adhesion, promote tumor invasion and EMT including downregulation of E-cadherin and upregulation of N-cadherin, Fibronectin and Slug of NPC cells. Conclusion: Our findings demonstrate that MMP-2 expression contributes to tumor aggressiveness and poor prognosis, and induces the occurrence of EMT in NPC.
Introduction
Nasopharyngeal carcinoma (NPC) is the most frequently diagnosed malignancy in Southern China (especially in people of Cantonese ancestry region), with a high incidence rate of 20-50 cases per 100,000 people each year. 1 Different from other head and neck cancers, most types of NPCs are undifferentiated squamous cell carcinomas, which are more aggressive and tend to have distant organ metastases. 2 Unfortunately, the precise molecules responsible for the progression and prognosis of NPC still remain incompletely understood.
Degradation of extracellular matrix (ECM) and penetration of basement membranes by matrix metalloproteinases (MMPs) are of eminent importance in invasion and metastasis. 3 Matrix metalloproteinase 2 (MMP-2), an important member of the MMPs family, has been shown to facilitate tumor invasion and metastasis and regulated by a variety of pathway. [4] [5] [6] [7] For example, Kenny HA and colleagues reported that MMP-2 regulated varian cancer (OvCa) invasion and metastasis through cleavage of ECM proteins Fibronectin (FN) into small fragments and promoted binding of OvCa cells to these FN fragments. 7 Our report recently has also demonstrated that MMP-2 could regulate non-small cell lung cancer invasion and modulated by LATS2. 8 Moreover, several MMP inhibitors have been considered extremely potential to attenuate tumor invasion and progression. [9] [10] [11] [12] Importantly, an increased expression of MMP-2 has been reported in a number of tumors including renal cell carcinoma, prostate cancer and ovarian cancer, and contributes to unfavorable outcome of patients. [13] [14] [15] These advances indicate that MMP-2 might be crucial for the development and progression of tumors. However, the prognostic impacts of tumoral MMP-2 expression on patients remain largely controversial. [16] [17] [18] For example, Pellikainen JM shows that high MMP-2 expression in carcinoma cells possessed no prognostic value for breast cancer. 16 Even more, Wong JC and colleagues had the opposite conclusion. They found that absence of tumoral MMP2 expression correlated with poor clinical outcomes in rectal cancer. 18 In consequence, the purpose of this study was to investigate and clarify the prognostic significance of neoplastic expression of MMP-2 in patients with NPC. Furthermore, the direct and functional impacts of MMP-2 overexpression on the invasive potential of NPC in vitro were also assessed.
Materials and methods

Patients and samples
One hundred and forty-four cancer tissues with NPC (median age, 49.4 y; range, 19-75 y; 107 male, 37 female) and 45 noncancerous pharynx tissues were collected from Affiliated Hospital of Guangdong Medical College and the People's Hospital of Gaozhou City, China. Prior to unitizing these tumor samples, approval from the Institutional Research Ethics Committee of Guangdong Medical College was obtained. Informed consent was obtained from all patients and the study was conducted in accordance with the principles of the Declaration of Helsinki. No radiation/chemotherapy treatment was applied to any of the patients included in this study. According to the WHO histological classification (2005), all of 144 NPC samples were classified as nonkeratinizing carcinoma. 19 All of the tumors were classified based on the UICC (2002) TNM classification and the clinicopathological features were described in detail as listed in Table S1 . The survival time was counted from the date of diagnosis to the follow-up deadline or date of death. The follow-up deadline was August 2011, and it was ranged from 10 to 106 months (median follow-up time, 65.7 months).
Immunohistochemical staining
Immunohistochemistry (IHC) analysis was performed as previously reported. 20 In brief, paraffin-embedded sections were baked at 60°C for 2 h followed by being deparaffinized in xylenes for 20 min and rehydrated in an ethanol gradient. The sections were submerged into EDTA buffer and boiled for 2 mins with high-pressure for antigenic retrieval. After natural cooling, the slides were treated with 3% H 2 O 2 to quench endogenous peroxidase activity, followed by incubation with 1% bovine serum albumin (BSA) to block non-specific binding. The slides were incubated with the MMP-2 rabbit polyclonal antibody (catalog ab110186, dilution 1:500; AbCam) overnight at 4°C. PBS buffer was used as negative controls, and colon cancer tissue was used as positive control. After PBS washing, the sections were reacted with the biotinylated secondary antibody (Zymed, San Francisco, CA). Sections were then visualized with 3,3′-diaminobenzidine (DAB) for 2 min, counterstained with hematoxylin and were mounted under a light microscopy. Pan-cytokeratin was used to distinguish neoplastic spindle cells from fibroblast cells or other stromal cells in NPC tissues.
Evaluation of immunohistochemical data
The degree of immunostaining were examined and scored independently by two pathologists based on the proportion of positively stained tumor cells and intensity of staining. The proportion of positive tumor cells was evaluated as follows: 0 (no positive tumor cells), 1 (<10% positive tumor cells), 2 (10-50% positive tumor cells), and 3 (>50% positive tumor cells). Staining intensity was graded according to the following criteria: 0 (no staining), 1 (weak staining, light yellow), 2 (modest staining, yellow brown), and 3 (strong staining, brown). We evaluated the expression of MMP-2 in NPC specimens (including tumor cells and tumor stroma) and non-cancerous nasopharyngeal tissues by determining the staining index (0, 1, 2, 3, 4, 6, or 9), which was calculated by multiplication of proportion and intensity.
The cutoff value for low and high expression level of MMP-2 was ≤4 (including 0, 1, 3, 4) and ≥6 (including 6 and 9), respectively. 21 Plasmids, lentivirus production, and transduction 
RNA isolation, reverse transcription and qRT-PCR
For mRNA analyses, total RNA from NPC cells was extracted with Trizol Reagent (TaKaRa) according to the protocol provided by the manufacturer. Total RNA was reversely transcribed with the PrimeScript RT reagent Kit (TaKaRa). Expression of mRNA analysis was performed using SYBR Green Master Mix (TaKaRa) as described using GAPDH for normalization on a Stratagene Mx3000P qRT-PCR System. The primers used for the amplification of the indicated genes were as previously described. 21, 22 All samples were normalized to internal controls and fold changes were calculated through relative quantification (2
−ΔΔCt
).
Cell-cell homotypic adhesion experiment 
Tumor invasion assays
Before invasion assay, matrigel (BD Biosciences) was added in the upper chamber overnight for dry. For transwell migration assay, 1×10 5 cells were seeded into the upper chamber (with 8.0 μm pores, BD Biosciences) in serum-free RPMI 1640. RPMI 1640 with 10% FBS was loaded in the lower compartment as chemo-attractant. After 20 hrs, the migrated or invaded cells were fixed with 100% methanol, stained with hematoxylin solution (Sigma), and counted in three randomly selected optical fields.
Statistical analysis
All statistical analyses were carried out using the SPSS13.0 (SPSS Inc., Chicago, IL). The correlation between the clinicopathologic features and MMP-2 expression was analyzed by the χ2 test. Survival curves were estimated using the KaplanMeier method and the log-rank test. Correlation coefficients between MMP-2 expression and variable factors were examined by the Spearman correlation method. Data were presented as mean ± SEM unless otherwise indicated of at least 3 independent experiments. Two-tailed Student's t-test was used for comparisons of 2 independent groups. Statistical significance was assessed by the independent-samples t-test (*P<0.05; **P<0.01).
Results
Cytoplasmic MMP-2 is highly expressed in tumor cells of NPC samples
The immunohistochemical staining for MMP-2 expression in 144 paraffin-embedded tissues of NPC were presented in Table S1 . Among 45 noncancerous tissues, negative or weak signals of MMP-2 were observed in non-cancerous nasopharyngeal epithelium ( Figure 1A and B), only 7 samples (15.6%) were highly expressed for MMP-2 ( Figure 1C and D) . MMP-2 was localized in the cytoplasm of cancer cells. Of the 144 tumors, 75 (52.1%) cases exhibited negative ( Figure 1E and F) or weak ( Figure 1G and H) cytoplasmic immunoreactivity for MMP-2, and 69 (47.9%) cases displayed high cytoplasmic staining ( Figure 1I and J). There was a significant increase in MMP-2 expression in NPC samples compared with noncancerous tissues. In addition, MMP-2 was high expressed in endothelial cells in tumor specimens and was used as internal positive controls ( Figure 1K and L).
Association of MMP-2 expression with clinicopathological variables and prognosis in NPC
The relationship between MMP-2 expression and clinicopathological variables of NPC was further analyzed. As summarized in Table 1 , there were no statistically significant differences between the expression levels of MMP-2 and sex (P=0.155), age (P=0 0.889), N classification (P=0.076). On the other side, MMP-2 protein expression was significantly associated with tumor histology ( Table 2 , univariate analysis shows that M classification was the most significant factor for the overall survival of NPC patients (P=0.000), followed by tumor stage (P=0.001), T classification (P=0.004) and N classification (P=0.013). However, neoplastic MMP-2 expression showed no prognostic value for overall survival time of patients (P=0.363; Table 2 ). As showed in Figure 2E , there was no significant difference in the postoperative survival according to MMP-2 expression in tumor cells. 
Discussion
MMP-2 belongs to a Zn
2+ dependent endopeptidase, which is known to be crucial for tumor invasion and metastasis due to their ability to degrade type IV collagen. 3 Moreover, increased expression of MMP-2 has been detected in a variety of human malignancies, and correlated closely with aggressive behaviors. [4] [5] [6] [7] In NPC, several indirect observations have indicated that the induction of MMP-2 by various pathways was involved in tumor cell invasion in vitro. 23, 24 Based on these observations, the determination of MMP-2 expression in NPC tissues seems to be important for better understanding of tumor In the current study, we observed that the expression levels of neoplastic MMP-2 expression were highly increased in NPC tissues compared with non-tumoral epithelium, suggesting that this molecule might be involved in the pathogenesis of NPC. Furthermore, high expression of MMP-2 linked strongly with various clinicopathologic features including tumor histology, T classification (depth of tumor infiltration), M classification and tumor stage. Our results suggest that MMP-2 is involved in the development and progression of NPC. On the other hand, Cui D et al reported that the expression levels of MMP-2 were positively correlated with lymph node metastasis in NPC. 25 In contrast, we failed to demonstrate a significant relationship between them, though patients with high MMP-2 expression had a tendency to lymph node metastasis. The inconsistency would be likely due to the different numbers of specimens used. Studies have demonstrated that growth factors and other genes, such as TGF-b, bone sialoprotein and prostaglandin E2, can regulate the expression levels of MMP-2 in various tumors. [26] [27] [28] [29] In MMP-2 expression. 30 Our recent report indicates that FoxM1 increases expression of MMPs including MMP1 and MMP9, whereas FoxM1 knockdown has the opposite effect. 31 As we know, EBV plays an important role in NPC pathogenesis through the regulation of MMPs. For example, Lu J et al showed that the EBV-related protein LMP1 could regulate the expression and activity of MMP-1 and confered the invasive properties of NPC. 32 Further studies are needed to investigate the correlation between EBV-related factors and MMP-2 induction in NPC. Epithelial-mesenchymal transition (EMT) is crucial for the initiation of invasion and metastasis for tumor progression. 33 Of note, as other groups reported previously, EMT may occur more frequently in the invasive front of tumors, including colorectal cancer, oesophageal squamous cell carcinoma, craniopharyngioma and papillary thyroid carcinoma. [34] [35] [36] [37] Recently, we also found that nuclear Vimentin and other EMTrelated markers were aberrantly expressed in tumor invasive front of NPC. 38 Interestingly, MMP-2 protein was also found to be overexpressed at the tumor invasive front, such as head and neck cancer, hepatocellular carcinoma and cervical cancer. [39] [40] [41] These findings suggest a possible relationship between MMP-2 and EMT in cancer progression. Actually, experimental data has shown that cancer cells that undergo EMT can enhance MMP-2 expression to facilitate cell invasion and metastasis. [42] [43] [44] In the current study, we observed that MMP-2 was markedly distributed at the invasive front of cancers. In some cases, the expression of MMP-2 was increased in tumor cells migrating the stroma with mesenchymal phenotypes, and these cells have been shown to be conferred with EMT properties in our recent study. 45 Furthermore, we found that neoplastic MMP-2 expression correlated closely with EMT-related markers including E-cadherin, N-cadherin, Fibronectin and Slug in NPC samples. Based on these observations, it seems likely that cancer cells expressing MMP-2 in NPC may have an advantage to invade and metastasize as compared to MMP-2-negative cancer cells. At last, a direct linking between EMT and MMP-2 in NPC in vitro was further examined. As expected, we found that upregulation of MMP-2 triggered EMT-like cellular marker changes and spindle-shaped morphology (a more aggressive phenotype), and enhanced the motility and invasion of NPC cells. These findings were strongly supported by MMP-2-mediated EMT in NPC specimens as described above. For the first time, we here clarify the correlation between EMT and MMP-2 in NPC.
In the past years, MMP-2 overexpression in tumor cells has been shown to contribute to unfavorable prognostic outcomes in various types of tumors. [13] [14] [15] 16 Similar to these findings, our findings also showed no prognostic significance of MMP-2 overexpression for overall time with NPC patients. However, we found that high MMP-2 expression could stratify survival time of patients in advanced clinical stage (III-IV). As we know, patients diagnosed at stage III-IV tend to have local recurrence and distant metastases after treatment. In consequence, we suggest that tumoral MMP-2 expression might be used as a potential biomarker for patients with late-stage.
Conclusion
We here show that high expression of MMP-2 was associated strongly with tumor aggressive features/phenotypes and poor survival in patients with stage III-IV. Finally, overexpression of MMP-2 enhanced the invasive abilities and induced EMT in NPC. Our results provide a deep insight into tumor aggressiveness and clinical outcomes of MMP-2 in tumor cells in NPC.
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